ParkinsonCanadaV1, Main, Exploration, bibRecord, 001544

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Identifieur interne : 001544 ( Main/Exploration ); précédent : 001543; suivant : 001545

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Auteurs : Evelyne Matteau [Canada] ; Nicolas Dupre [Canada] ; Mélanie Langlois [Canada] ; Pierre Provencher [Canada] ; Martine Simard [Canada]

Source :

Journal of geriatric psychiatry and neurology [ 0891-9887 ] ; 2012.

RBID : Pascal:12-0276402

Descripteurs français

Pascal (Inist)
- Démence, Validité, Echelle d'évaluation, Maladie de Parkinson, Dépistage, Criblage, Trouble cognitif, Gériatrie, Personne âgée, Déficit cognitif léger, Gérontologie, Neurologie.
Wicri :
- topic : Personne âgée, Gérontologie, Neurologie.

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Attention, Cognitive Dysfunction (complications), Cognitive Dysfunction (diagnosis), Cognitive Dysfunction (psychology), Cognitive disorder, Cross-Sectional Studies, Dementia, Dementia (complications), Dementia (diagnosis), Dementia (psychology), Elderly, Evaluation scale, Female, Geriatrics, Gerontology, Humans, Male, Medical screening, Memory, Middle Aged, Neurology, Neuropsychological Tests, Parkinson Disease (diagnosis), Parkinson disease, Psychiatric Status Rating Scales, Reproducibility of Results, Screening, Sensitivity and Specificity, Validity, mild cognitive impairment.
MESH :
- complications : Cognitive Dysfunction, Dementia.
- diagnosis : Cognitive Dysfunction, Dementia, Parkinson Disease.
- psychology : Cognitive Dysfunction, Dementia.
- Aged, Aged, 80 and over, Attention, Cross-Sectional Studies, Female, Humans, Male, Memory, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Reproducibility of Results, Sensitivity and Specificity.

Abstract

The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia</title>
<author><name sortKey="Matteau, Evelyne" sort="Matteau, Evelyne" uniqKey="Matteau E" first="Evelyne" last="Matteau">Evelyne Matteau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec, Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec, Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Provencher, Pierre" sort="Provencher, Pierre" uniqKey="Provencher P" first="Pierre" last="Provencher">Pierre Provencher</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simard, Martine" sort="Simard, Martine" uniqKey="Simard M" first="Martine" last="Simard">Martine Simard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0276402</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0276402 INIST</idno>
<idno type="RBID">Pascal:12-0276402</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000184</idno>
<idno type="stanalyst">FRANCIS 12-0276402 INIST</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000256</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A68</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000187</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000187</idno>
<idno type="wicri:doubleKey">0891-9887:2012:Matteau E:clinical:validity:of</idno>
<idno type="wicri:Area/Main/Merge">001601</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:22689702</idno>
<idno type="wicri:Area/PubMed/Corpus">000A63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A63</idno>
<idno type="wicri:Area/PubMed/Curation">000A63</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A63</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A63</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A63</idno>
<idno type="wicri:Area/Ncbi/Merge">001170</idno>
<idno type="wicri:Area/Ncbi/Curation">001170</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001170</idno>
<idno type="wicri:doubleKey">0891-9887:2012:Matteau E:clinical:validity:of</idno>
<idno type="wicri:Area/Main/Merge">001299</idno>
<idno type="wicri:Area/Main/Curation">001544</idno>
<idno type="wicri:Area/Main/Exploration">001544</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia</title>
<author><name sortKey="Matteau, Evelyne" sort="Matteau, Evelyne" uniqKey="Matteau E" first="Evelyne" last="Matteau">Evelyne Matteau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec, Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Medicine, Université Laval</s1>
<s2>Quebec, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec, Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Provencher, Pierre" sort="Provencher, Pierre" uniqKey="Provencher P" first="Pierre" last="Provencher">Pierre Provencher</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, CHA-Enfant-Jésus</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simard, Martine" sort="Simard, Martine" uniqKey="Simard M" first="Martine" last="Simard">Martine Simard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>École de psychologie, Universite Laval and Centre de Recherche Universite Laval Robert-Giffard</s1>
<s2>Quebec City, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec City, QC</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of geriatric psychiatry and neurology</title>
<title level="j" type="abbreviated">J. geriatr. psychiatry neurol.</title>
<idno type="ISSN">0891-9887</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of geriatric psychiatry and neurology</title>
<title level="j" type="abbreviated">J. geriatr. psychiatry neurol.</title>
<idno type="ISSN">0891-9887</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Attention</term>
<term>Cognitive Dysfunction (complications)</term>
<term>Cognitive Dysfunction (diagnosis)</term>
<term>Cognitive Dysfunction (psychology)</term>
<term>Cognitive disorder</term>
<term>Cross-Sectional Studies</term>
<term>Dementia</term>
<term>Dementia (complications)</term>
<term>Dementia (diagnosis)</term>
<term>Dementia (psychology)</term>
<term>Elderly</term>
<term>Evaluation scale</term>
<term>Female</term>
<term>Geriatrics</term>
<term>Gerontology</term>
<term>Humans</term>
<term>Male</term>
<term>Medical screening</term>
<term>Memory</term>
<term>Middle Aged</term>
<term>Neurology</term>
<term>Neuropsychological Tests</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson disease</term>
<term>Psychiatric Status Rating Scales</term>
<term>Reproducibility of Results</term>
<term>Screening</term>
<term>Sensitivity and Specificity</term>
<term>Validity</term>
<term>mild cognitive impairment</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cognitive Dysfunction</term>
<term>Dementia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognitive Dysfunction</term>
<term>Dementia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Cognitive Dysfunction</term>
<term>Dementia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Attention</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Memory</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
<term>Psychiatric Status Rating Scales</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Démence</term>
<term>Validité</term>
<term>Echelle d'évaluation</term>
<term>Maladie de Parkinson</term>
<term>Dépistage</term>
<term>Criblage</term>
<term>Trouble cognitif</term>
<term>Gériatrie</term>
<term>Personne âgée</term>
<term>Déficit cognitif léger</term>
<term>Gérontologie</term>
<term>Neurologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
<term>Gérontologie</term>
<term>Neurologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The utility of the Mattis Dementia Rating Scale 2 (MDRS-2) in screening for dementia in Parkinson disease (PD) is well documented. However, little is known about its sensitivity to mild cognitive impairment in PD (PD-MCI). This study sought to document the validity of the MDRS-2 for diagnoses of PD-MCI and dementia in PD (PDD). Twenty-two healthy controls (HCs), 22 PD-MCI, and 16 PDD were compared on each MDRS-2 subscales and MDRS-2 total standard scores. Patients with PDD performed significantly worse than the other groups (all Ps < .05) on the MDRS-2 total and on all subscales, except attention. PD-MCI had significant lower scores than HCs on the MDRS-2 total and on initiation/perseveration and memory subscales. The optimal cutoff score for PD-MCI diagnosis was ≤ 140/144 and < 132/144 for PDD. These findings suggest that MDRS-2 is a useful tool to identify dementia but that there might be a ceiling effect in the MDRS-2 cutoff score to diagnose MCI in PD.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Matteau, Evelyne" sort="Matteau, Evelyne" uniqKey="Matteau E" first="Evelyne" last="Matteau">Evelyne Matteau</name>
</noRegion>
<name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<name sortKey="Dupre, Nicolas" sort="Dupre, Nicolas" uniqKey="Dupre N" first="Nicolas" last="Dupre">Nicolas Dupre</name>
<name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<name sortKey="Langlois, Melanie" sort="Langlois, Melanie" uniqKey="Langlois M" first="Mélanie" last="Langlois">Mélanie Langlois</name>
<name sortKey="Provencher, Pierre" sort="Provencher, Pierre" uniqKey="Provencher P" first="Pierre" last="Provencher">Pierre Provencher</name>
<name sortKey="Simard, Martine" sort="Simard, Martine" uniqKey="Simard M" first="Martine" last="Simard">Martine Simard</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001544 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001544 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0276402
   |texte=   Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.